Aktuellt
SENASTE
Redeye is encouraged to learn that RLS has made progress in the Netherlands. ChloraSolv is now listed on the Z-Index and will thus be fully reimbursed by the National Health Care Institute (Zorginstituut Nederland). We continue to argue that RLS has an exciting year ahead and that the share is very attractive at current share price levels.
LÄS MER
